Hillstream BioPharma Analyst Ratings
Hillstream BioPharma Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/17/2023 | — | Dawson James | Downgrades | Buy → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 07/17/2023 | — | 道森·詹姆斯 | 降級 | 買入 → 中性 |
What is the target price for Hillstream BioPharma (HILS)?
Hillstream BioPharma（HILS）的目標價格是多少？
The latest price target for Hillstream BioPharma (NASDAQ: HILS) was reported by Dawson James on July 17, 2023. The analyst firm set a price target for $0.00 expecting HILS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
道森·詹姆斯於2023年7月17日公佈了Hillstream BioPharma（納斯達克股票代碼：HILS）的最新目標股價。這家分析公司將目標股價定爲0.00美元，預計HILS將在12個月內跌至-100.00％（可能下跌-100.00％）。去年有1家分析公司公佈了評級。
What is the most recent analyst rating for Hillstream BioPharma (HILS)?
Hillstream BioPharma（HILS）的最新分析師評級是多少？
The latest analyst rating for Hillstream BioPharma (NASDAQ: HILS) was provided by Dawson James, and Hillstream BioPharma downgraded their neutral rating.
Hillstream BioPharma（納斯達克股票代碼：HILS）的最新分析師評級由道森·詹姆斯提供，Hillstream BioPharma下調了中性評級。
When is the next analyst rating going to be posted or updated for Hillstream BioPharma (HILS)?
Hillstream BioPharma（HILS）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hillstream BioPharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hillstream BioPharma was filed on July 17, 2023 so you should expect the next rating to be made available sometime around July 17, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Hillstream BioPharma的高管和客戶交談以及聽取財報電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Hillstream BioPharma的最後一次評級是在2023年7月17日提交的，因此你應該預計下一個評級將在2024年7月17日左右公佈。
Is the Analyst Rating Hillstream BioPharma (HILS) correct?
分析師對 Hillstream BioPharma (HILS) 的評級正確嗎？
While ratings are subjective and will change, the latest Hillstream BioPharma (HILS) rating was a downgraded with a price target of $0.00 to $0.00. The current price Hillstream BioPharma (HILS) is trading at is $0.37, which is out of the analyst's predicted range.
儘管評級是主觀的，會發生變化，但最新的Hillstream BioPharma（HILS）評級被下調，目標股價爲0.00美元至0.00美元。Hillstream BioPharma（HILS）目前的交易價格爲0.37美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。